Quick Answer
Oric Pharmaceuticals, Inc. reported Shares Outstanding of 98.53 million shares for fiscal year 2025.
Oric Pharmaceuticals, Inc. Shares Outstanding — Annual History
| Fiscal Year | Shares Outstanding | YoY Change |
|---|---|---|
| 2025 | 98.53M | +38.7% |
| 2024 | 71.02M | +29.4% |
| 2023 | 54.87M | +21.7% |
| 2022 | 45.09M | +14.4% |
| 2021 | 39.43M | +7.5% |
| 2020 | 36.67M | +1748.2% |
| 2019 | 1.98M | — |
Quarterly Shares Outstanding
| Quarter Ending | Shares Outstanding | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | 97.28M | +37.9% | +12.9% |
| June 30, 2025 | 86.19M | +27.4% | +21.3% |
| March 31, 2025 | 71.08M | +5.4% | +0.1% |
| December 31, 2024 | 71.02M | +29.4% | +0.7% |
| September 30, 2024 | 70.56M | +29.4% | +4.3% |
| June 30, 2024 | 67.67M | +24.1% | +0.4% |
| March 31, 2024 | 67.42M | +49.5% | +22.9% |
| December 31, 2023 | 54.87M | +21.7% | +0.6% |
- Oric Pharmaceuticals, Inc. showed an increase of +38.7% in Shares Outstanding compared to the prior fiscal year.
- Over the 2019–2025 period, Oric Pharmaceuticals, Inc.’s shares outstanding has grown by 4865.6% (from 1.98 million shares to 98.53 million shares).
- The most recent figure is from Oric Pharmaceuticals, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on February 23, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: